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Abstract
Aromatase (P450arom, CYP19A1) is the terminal enzyme in the synthesis of the steroid hormone
family of estrogens. Not surprisingly, this enzyme has structural similarities between the limited
number of species studied thus far. This study examined the structure of aromatases from four
diverse Australian species including amarsupial (tammarwallaby;Macropus eugenii), monotreme
(platypus;Ornithorhynchus anatinus), ratite (emu; Dromaius novaehollandiae) and lizard (bearded
dragon; Pogona vitticeps). We successfully built homologymodels for each species, using the only
crystallographically determined structure available, human aromatase. The amino acid sequences
showed high amino acid sequence identity to the human aromatase: wallaby 81%, platypus 73%,
emu 75% and bearded dragon at 74%. The overall structure was highly conserved among the five
species, although there were non-secondary structures (loops and bends) that were variable and
flexible that may result in some differences in catalytic activity. At the N-terminal regions, there
were deletions and variations that suggest that functional distinctions may be found. We found
that the active sites of all these proteins were identical, except for a slight variation in the emu. The
electrostatic potential across the surfaces of these aromatases highlighted likely variations to the
protein-protein interactions of these enzymes with both redox partner cytochrome P450 reductase
and possibly homodimerization in the case of the platypus, which has been postulated for the
human aromatase enzyme. Given the high natural selection pressures on reproductive strategies,
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the relatively high degree of conservation of aromatase sequence and structure across species
suggests that there is biochemically very little scope for changes to have evolved without the loss
of enzyme activity.
Key words: evolution of steroidogenesis, aromatase, molecular modeling, estrogen.
Introduction
The synthesis of the steroid hormone family of estrogens is a defining
step in the reproductive ability of animal species. The biosynthesis of
steroid hormones begins with cholesterol, which is converted into a
variety of steroid hormones by a series of enzymatically catalyzed
chemical reactions. A key step in estrogen production is a final
transformation of the precursors, androstenedione or testosterone,
into estrogens by a three-step, six-electron process. It is catalyzed by
a cytochrome P450 enzyme called aromatase (P450arom,CYP19A1)
[1, 2].
Cytochrome P450 enzymes are a superfamily of heme-thiolate
enzymes that achieve stereoselective insertion of an oxygen atom into
an otherwise inactive carbon-hydrogen bond [3–5]. Two electrons
from the reducing nicotinamide adenine dinucleotide phosphate
(NADPH) are required for the catalytic cycle. Electrons are trans-
ferred to the microsomal aromatase from a membrane bound flavo-
protein, NADPH cytochrome P450 reductase (CPR). This requires a
specific protein-protein interaction between CPR and aromatase.
Since estrogens are essential for reproduction, which is under
intense natural selection pressures, estrogen biosynthesis dictates the
fitness and success of many higher order species across evolution.
Additionally, estrogen hasmany different regulatory roles in different
species [1]. This is achieved partially by the production of estrogen by
different tissues, such as gonads, placenta, trophoblast and brain. To
enable tissue-specific expression of the aromatase gene (CYP19A1)
for estrogen production, the pig family replicated the gene twice
[6–11]. In contrast, most other mammalian species replicated
only the first exon, enabling the use of alternative tissue-specific
promoters [1].
To date, X-ray crystallography has resolved the structural details
of only one natively isolated aromatase, obtained from human
placenta [12]. Since then, recombinantly modified human aromatase
has been expressed and structurally characterized by Ghosh and
colleagues [13, 14]. However, aromatase has not been crystallized
from any other species. Furthermore, despite the essential importance
of this enzyme, aromatase has only been isolated and sequenced from
a few animal species, and even fewer have been characterized in terms
of catalytic activity [1, 15].
Previously, we investigated the suiform family, including pigs,
in which ancient gene duplication has resulted in three tissue-
specific aromatase. Employing a range of biophysical (Quartz crystal
microbalance with Dissipation monitoring using biomimetic lipid
bilayers) and biochemical methods (FRET and enzyme kinetics
assays), we previously compared the human with porcine aromatase
enzymes [16]. Experimental analysis of human P450arom and
porcine gonadal [6], placental [15] and the pre-implantation
blastocyst [7] P450arom displays significantly different kinetics. The
human aromatase has a catalytic efficiency (Vmax/Km, min−1/μmol)
of 14.1 compared with porcine placental and gonadal isozyme,
which are 19.2 and 7.8, respectively [16]. Selecting the least
catalytically efficient porcine isozyme (gonadal) of aromatase
to compare with the human aromatase, we undertook sequence
analysis, building homological models for structural comparisons,
and finally molecular dynamics simulations and calculations that
supported differences in oligomerization in vitro. This in silico
analysis found that homodimerization occurs with human aromatase
[17], but this appears not to occur with the porcine gonadal
aromatase, and this could be the reason for the differences in enzyme
kinetics between the two species [16]. These computational data
were further supported by in vitro biophysical studies using purified
recombinant and wild-type aromatase proteins with or without their
redox partner CPR and also visualized by Atomic Force Microscopy
(AFM) in solution at a membrane interface [17]. These data led us
to propose that other species among the evolutionary tree might also
have developed alternative ways to regulate the activity of aromatase.
The availability of genomes for many species provides an
opportunity to data-mine aromatase sequences across representative
species of classes that lie at essential junctures across evolution.
By doing this, we may begin to elucidate subtle evolutionary
differences between these species which has led to their survival.
Here we analyzed the aromatase enzyme across four Australian
species that included the classes of reptilia, aves and mammalia.
Specifically, bearded dragon (Pogona vitticeps), emu (Dromaius
novaehollandiae), platypus (Ornithorhynchus anatinus) and tammar
wallaby (Macropus eugenii) were compared with human P450arom.
Materials and methods
General methods
Analysis of the complexes was conducted using NAMD [18] and
figures constructed using Pymol (The PyMOL Molecular Graphics
System, Version 2.0 Schrödinger, LLC.) and Chemaxon software
(ChemAxon Ltd.).
Sequences and alignment
Amino acid sequences were downloaded from NCBI for human
(NP_001334185.1), bearded dragon (XP_020645700.1) and platy-
pus (XP_003429099.2) species. The tammar wallaby aromatase
used an unpublished sequence provided by Professor Marilyn Ren-
free (University of Melbourne) and colleagues as noted in our
acknowledgements. The emu sequence (XP_025952868.1) was pro-
vided prior to publication [19] by Dr. Tim Sackton of Harvard
University with assistance from Dr Chris Smith, Monash University.
Alignment of sequences was undertaken using Clustal W 2.1 [20].
Species-specific amino acids are annotated by the species name, i.e.,
h = human, w = wallaby, p = platypus, e = emu and d = dragon.
Homology modeling
Three-dimensional models of the wallaby, platypus, emu and dragon
aromatase were built using the crystal structure of human aromatase
as a template (Protein Data Bank entry no. 3EQM) inModeller v9.11
[21] and Swiss Model [22]. Model quality was determined using
the Structure Assessment module in Swiss Model, which includes
a combination of Ramachandran Plots, MolProbity [23], QMean
[24] and visual analysis (Supplementary Figure S1). The models
that scored the highest across multiple categories were utilized in
further analysis. Analysis of the resultant models suggested that
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Swiss Model was able to create higher quality models of the dragon
species. Conversely, the Modeller program was able to create higher
quality models using the wallaby, platypus and emu species. Flexible
regions were removed from the N- and C-termini. The heme and
androstenedione from the human structure were merged into the
Australian animal structures and minimized under the Tripos Force
Field for 10 000 iterations or until convergence was reached. Local
protein contact potentials were generated with vacuum electrostatics
in Pymol, using default settings (The PyMOL Molecular Graphics
System, Version 2.0 Schrödinger, LLC New York, NY, 2020).
Molecular dynamics simulations
The molecular dynamics programNAMD [18] was used to minimize
the protein models. The proteins were initially solvated with TIP3P
water using the Solvate plugin within VMD version 1.9 (VMD—
Visual Molecular Dynamics, molecular graphics software, https://
www.ks.uiuc.edu/Research/vmd/). The rotate to minimize volume
was selected, the boundary reduced to 1.8 and the box padding
increased to 20 Å in all directions; all other parameters were kept
at default. Charges were then neutralized with NaCl using the
autoionize plugin within VMD version 1.9 using default settings.
Each structure was minimized and equalized for 1 nanosecond (2
femtosecond time step) under the CHARMM27 all-atom force field
at 298 K. Langevin dynamics were used with group pressure, and
Langevin piston was turned on. Trajectory snapshots were collected
every picosecond. After approximately 200 picoseconds, the average
root mean square deviation (RMSD) had leveled to approximately
2 Å and analysis was conducted after this time point. The total energy
of the system was calculated during and at the end of the simulation
runs and averaged.
Results and discussion
Amino acid sequence comparisons
The amino acid sequences from the four animal sequences were
aligned to the human sequence (Figure 1). The sequences from the
four animals showed high amino acid sequence identity to the human
aromatase; wallaby 81%, platypus 73%, emu 75% and bearded
dragon at 74%. The wallaby had the highest sequence similarity
to human which is not surprising as evolutionarily they are the
most similar of the five species. Regardless, there were still some
major sequence differences between the P450arom of the different
species. A closer look at these differences showed that some may
impact their ability to function in the same manner as the human
aromatase. The biggest difference between the aromatase of all four
species was at the N-termini. Specifically, when compared to the
human, the wallaby is truncated at the N-terminus, with 69 residues
fewer than the human aromatase. Importantly, in the crystallized
human aromatase [12], this region forms the A-helix. Thus, the lack
of these amino acids may affect the overall 3D structure of the
wallaby P450arom. The N-terminal region anchors the enzyme into
the membrane bilayer; thus, the significance of the species variation
across this region could have a role in enzyme mobility and thus
function.
We also assessed the ability of the N-terminus of all species
to be a part of a transmembrane domain using G Predictor [25,
26]. This program uses the distribution pattern of amino acids
present in a trans-membrane region (typically an alpha helix) to
well defined physicochemical properties, that are employed to enable
the biological machinery to send the protein to the membrane for
insertion into the endoplasmic reticulum [26]. In this program,
the amino acid sequences are inputs, and the graphical outputs
(Supplementary Figure S2) show the predicted Gapp values against
the position in the sequence for different helix lengths (L). Notably,
in all our species, a trans-membrane helix is predicted within the
first 50 amino acids (Supplementary Figure S2). However, the N-
terminal helix of the wallaby aromatase was the least likely to insert
as a transmembrane domain, as the expected change in predicted
free energy (−G) was slightly positive. However, the authors of
the G Predictor program note that “In principle, a negative value
of Gapp indicates that the sequence is predicted to be recognized
as a trans-membrane helix by the Sec [27] and integrated into the
membrane. On the other hand, a positive value of Gapp does not
necessarily imply that the sequence is not trans-membrane. Even if
the predictedGapp value is positive, that does not necessarily imply
that the sequence entered cannot be trans-membrane. All it suggests
is that the segment would not be inserted efficiently by itself and
may need stabilizing interactions from surrounding helices” (http://
dgpred.cbr.su.se/index.php?p=instructions). Thus, these data suggest
that the wallaby aromatase sequence is less convincing as a trans-
membrane helix region, especially with charged residues (Lys, Glu
and Arg) present and which are not observed in the N-terminal trans-
membrane helix in the other species. Further biophysical data using
expressed wallaby aromatase enzyme would be required to provide
a definitive functional significance for this region.
There are subtle variations in specific amino acid residues
between species that may be associated with activity and function
of the aromatase. For example, one of the residues that we have
reported as capable of forming a functional homodimer, h290D
[16], is also found in the platypus (p299D) and the emu (e289D),
whereas, the wallaby and dragon have w221E and d290E, respectively.
This residue is located within the human H-helix and together
with other charged residues creates an electrostatic homodimeric
interface for human aromatase [16]. In this study, we compared
the human with the porcine gonadal (pg) aromatase structure
using homology models and molecular dynamics and found that
the porcine gonadal aromatase was more stable as a monomer.
Additionally, those data were supported by dramatic differences in
enzyme activities and biophysical properties [16]. Thus, the dimeric
human aromatase exhibited a close salt-bridge interaction at 2.6 Å,
between h290D· · ·h293R, whereas the porcine gonadal aromatase
showed no contact at the equivalent residues, pg288E | pg291K
suggesting it was less likely to form a stable dimer, and we proposed
that it is likely to function as a monomer. The equivalent residues
in the species investigated here are w221E· · ·w224G, p299D· · · p302R,
e289D· · · e292A and d290E· · · d293G. This implies that the platypus is
the only species we examined that is likely to exhibit activity and
catalytic efficiency of aromatase similar to that found in humans.
More detailed investigation, including expression and determination
of the activities of the wallaby, emu and dragon P450arom is now
required.
We examined the CPR-binding region, the heme-binding domain
and the substrate-binding site. The residues which form the CPR
binding region in humans are predominately positively charged
arginine (K) and lysine (R) residues, which allow for the electrostatic
interaction with the CPR [28]. In the human, this consists of eight
positively charged residues: 108K,142K,145R,150K,352K, 354K, 420K and
425R; highlighted in green in Figure 1. The only difference between
all four species is a single amino acid difference in the emu sequence
where the human 352K is replaced by an asparagine (N). This minor
change from a basic to an amidic amino acid would be expected
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Figure 1. Amino acid sequence of P450arom from wallaby (unpublished), platypus (XP_003429099.2), emu (XP_025952868.1) and dragon (XP_020645700.1)
aligned with the human (NP_001334185.1) sequence. Highlighted in gray are the long helices, in blue are the beta strands and in yellow are the small helices.
Amino acids marked in green represent those predicted to be involved in CPR binding. Below the aligned sequences is a code whereby, ∗ indicates amino acids
that are fully conserved,: indicates amino acids with properties that are strongly conserved and. indicates amino acids with properties that are weakly conserved
across species.
to have only a slight influence on the binding affinity of the CPR.
In comparison with the porcine aromatases, the positively charged
amino acids required for CPR binding were identical to the human
except for the porcine blastocyst isozyme that had 352E [16]. Thus,
it is difficult to gauge whether this single change to the CPR binding
in the emu will impact the strength of the protein-protein interaction
or affect the nature of the electron transfer needed between CPR and
P450arom. Site-directed mutagenesis and enzyme activity studies on
expressed aromatase would be required and were beyond the scope
of this study.
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Table 1. Total energy for each species obtained by molecular dynamics minimizations of P450arom structures created using Swiss Model
and Modeller.
Total Energy/(kcal/mol) wallaby platypus emu dragon
Minimum −154 367 −167 206 −161 000 −161 009
Maximum −154 344 −167 189 −159 480 −160 993
Mean −154 355 −167 200 −160 160 −161 001
S.D. 11.86 9.136 772.5 11.24
S.E.M. 6.850 5.275 446.0 7.948
In the heme-binding domain, there are more amino acid dif-
ferences between the human (430FGFGPRGCA) and the other four
species. This is surprising as all species are expected to bind heme.
The wallaby sequence, also being a mammal, is predicted to have
identical heme-binding amino acids to the human. The next most
similar sequence to the human is the emu, which has a single minor
conservative residue change (438A → V), which we expect to have
no significant impact on the binding of the heme. The platypus also
has a single difference from the human sequence; however, this is a
non-polar to polar mutation (436G → S), which, depending on the
location, may reduce hydrophobic interactions and thus the binding
affinity for the heme. Interestingly, the bearded dragon sequence
had both the conservative platypus change (438A → V) and the less
conservative emu change (436G → S), plus another non-polar to
polar substitution (432F → S). Since heme is essential for the transfer
of electrons, these changes suggest that they do not interfere with
binding to a heme group in a major way.
In the substrate-binding site, there is a requirement to bind
the hydrophobic androstenedione and allow for its conversion to
estrone. Therefore, the active site of aromatase needs to consist
of predominately hydrophobic, non-polar residues. According to
Ghosh et al. [12], in the human crystal structure, the residues which
form direct van der Waals interactions with androstenedione are
115R, 133I, 134F, 221F, 224W, 306A, 310T, 370V, 373V, 374M and 477L.
However, in order to orient the substrate correctly and to stabilize
intermediates, there needs to be polar interactions with the two distal
oxygens of the androstenedione. In the human crystal structure,
this is achieved via amino acids 309D and 374M. Specifically, the
309D interacts with O1 (oxygen 1) on the androstenedione via its
side-chain and the backbone of 374M interacts with O2 (oxygen 2)
on of androstenedione [12]. All of the aromatase residues directly
interacting with androstenedione mentioned above are common
between all five species with the exception of the emu that has a
conservative residue substitution at h373V becoming a similarly non-
polar amino acid isoleucine (I) in the emu sequence (e372I).
Homology models were successfully created for each
species
Using both Swiss Model and Modeller, we were able to success-
fully create high quality models of the wallaby, platypus, emu and
dragon aromatase proteins. For further analysis, we used the Swiss
Model dragon models and the models created by Modeller for the
wallaby, platypus and emu. Amino acids computationally predicted
to be unstructured were deleted from both the N- and C- termini.
Molecular dynamics minimizations were then undertaken on models
of each species. The total energies of each species were found
to be similar (Table 1); therefore, visual analysis was required to
identify specific differences between the structures of each animal
species.
The homology models were aligned in Pymol (Figure 2), and
the ligand (androstenedione) and heme were manually docked in
and re-minimized. Based on the reasonably high sequence homology,
it was not unexpected that all species aligned relatively well. The
root mean square deviation (RMSD) was calculated by aligning
the alpha carbons of the other species to the human structure
(Supplementary Table S1 and Supplementary Figure S1). This gave
RMSDs of 0.12, 0.19, 0.23 and 0.12 Å for wallaby, platypus, dragon
and emu, respectively. Although the wallaby had the closest RMSD
to the human, as anticipated from the sequence alignments, the
wallaby is missing structure at the N-terminus when compared to
the human crystal structure. Specifically, this consists of two alpha
helices and approximately one and a half beta strands from the
first beta sheet. Although not unexpected, the extent of the missing
structural components was surprising, as from the sequence, we only
expected a single alpha helix not to be present.
Visually, the backbone alignment of all the other species looks
structurally similar to the human crystal structure. At approximately
0.1 Å worse than the other species RMSD, the dragon only had very
minor differences in overall structural features. Specifically, this was
just some very minor differences at the C-terminus, perhaps due to
the two amino acids truncation in the sequence when compared to
the human.
Local protein contact potentials using vacuum electrostatics were
successfully generated for each animal model using Pymol. The sur-
face charges (Figure 3) represent the surface electrostatic morphol-
ogy with regions of positive (blue), negative (red) and neutral (white)
surface potential. The human aromatase (Figure 3A) illustrates the
positively charged (R/K) residues, shown in blue spheres that are
needed to bind the redox partner protein CPR. These residues,
discussed earlier, are all conserved across species (see Figure 1) except
for the emu sequence in which the human 352K is replaced by an
asparagine (N). In Figure 3A, this substitution reduces the positive
charge (Supplementary Figure S4); however, the reduction from eight
to seven positive charges is not expected to have a significant impact
on the overall strength of CPR binding, although possibly it could
impact the coupling efficiency of the electron transfer form CPR of
aromatase in the emu.
Another feature of interest is the hypothesized human aromatase
dimer interface [16]. The 90◦ rotation of Figure 3A shows the
homodimerization interface (Figure 3B). As discussed above,
analysis of the amino acid residues that form a close salt bridge
in the postulated human aromatase dimer interface suggests that
the platypus aromatase is the only one of these five species likely
to exhibit activity and catalytic efficiency of aromatase similar to
that found in the human. In Figures 3C–F, the animal species are
oriented similarly to the human to show the equivalent interface used
by the human aromatase for homodimerization. Interestingly, the
charge distribution across the wallaby, platypus, emu and dragon has
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Figure 2. Alignment of the Australian animal homology models with the human P450arom crystal structure. Shown is the human structure (magenta) with the
dragon (green), emu (blue), platypus (gray) and wallaby (wheat) using an alpha carbon alignment. Also shown is the position of the heme (orange spheres)
and the androstenedione (yellow spheres) as crystallized in the human crystal structure.
Figure 3. Surface electrostatic potential for all species. The human aromatase showing (A) the CPR binding site with positively charged resides (R/K) highlighted
as light blue spheres, (B) rotation of (A) by 90◦ to show the face for protein-protein homodimerization [16] interface. (C–F) The equivalent homodimerization
face for the wallaby, platypus, emu and dragon, respectively. All structures are with the N-termini orientated at the bottom (lime green) that represents the
membrane anchor.
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Figure 4.Human, dragon and wallaby have almost identical substrate binding sites. (A) Alignment of the human (magenta), dragon (green) and wallaby (wheat)
and platypus (gray) models highlights how similar these sites are. The amino acids which interact with the androstenedione (yellow) are shown as sticks and
labeled in the individual figures of (B) human only, (C) dragon only and (D) wallaby only and (E) platypus only. The heme is shown in orange.
Figure 5. (A) The emu amino acids (blue) predicted to interact with androstenedione (yellow). (B) A close-up view of the h373V (magenta) to e407I (blue) amino
acid difference in the active site. The heme is shown in orange.
broadly similar patterns, but are different to the human aromatase,
that has a “stripe” of positive charge flanked by negative charges
along the dimerization interface. These models are also shown in
Supplementary Figure S3, where each aromatase structure is rotated
through 90◦ stages to provide a 3D visualization of the electrostatic
surfaces. Supplementary Figure S4 provides a qualitative but relative
comparison between the species, and the subtle changes observed
could in turn translate into altered activity of the respective
aromatases.
Most species have identical substrate binding sites
Computational and visual analysis of the models showed that the
active site residues of the human, dragon, platypus and wallaby
are very similar. This is interesting, as the dragon not only has less
sequence identity to the human than the wallaby, but the structural
model of the dragon also has a higher RMSD than the wallaby, when
compared to the human (Figure 4).
The human structure has 12 hydrophobic interactions with
androstenedione (h133I, h134F, h221F, h224W, h306A, h309D, h310T, h370V,
h372L, h373V, h374M and h477L). These equivalent residues are found
in the dragon, platypus and the wallaby and thus as expected, these
same hydrophobic interactions are observed. As expected from the
sequence analysis, the oxygens of the androstenedione are orientated
into place by hydrogen bonds between the side-chain of 309D and O1
and 374M and O2 for human. Evolutionary, this might be interesting,
as subtle variation in these structures could alter the sequential
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hydroxylation reactions that result in aromatization of the steroid
A-ring.
There are small differences between human and emu
There is one very small difference in the amino acid sequences of
human and emu, which was predicted to have a very minor effect on
androstenedione binding. Namely, h373V is an e407I in emu. Visual
analysis of this residue shows that they align perfectly (Figure 5)
with the extra carbon of e407I predicted to give a slight increase in
hydrophobic interactions with the heme and the androstenedione.
Conclusion
The homology models built for wallaby, platypus, emu and dragon
represent a wide and diverse variation in species and yet, these show
good 3D structural similarities. The amino acid sequences from the
four Australian animals showed high amino acid sequence identity
to the human aromatase; wallaby 81%, platypus 73%, emu 75%
and bearded dragon at 74%. In the 3D structures of all the enzymes,
with regard to the active sites, we found that the dragon, platypus
and wallaby had identical substrate binding sites to the human aro-
matase. Comparisons between the emu and the human showed only
small differences with variations due to conserved amino acid substi-
tutions. Among the five species, the aromatase structure was highly
conserved, although there were non-secondary structures (loops and
bends) that were variable and flexible, and these may result in some
differences in the catalytic activity. Certainly, the electrostatic poten-
tial across the surfaces of these aromatases highlighted likely varia-
tions to the protein-protein interactions of these enzymes with CPR
and possibly, like the porcine gonadal isoform, an inability to homod-
imerize in the case of the wallaby, emu and dragon. Given the high
natural selection pressures on reproductive strategies, the relatively
high degree of conservation of aromatase sequence and structure
across species suggests that there is biochemically very little scope
for changes to have evolved whilst still retaining aromatase activity.
Supplementary data
Supplementary data are available at BIOLRE online.
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